Sweat test practice in pediatric pulmonology after introduction of cystic fibrosis newborn screening
Authors:
- Céline GrimaldiCGCéline Grimaldi
- François BrémontFBFrançois Brémont
- Michèle Berlioz-BaudoinMBMichèle Berlioz-Baudoin
- Jacques BrouardJBJacques Brouard
- Harriet CorvolHCHarriet Corvol
- Laure CoudercLCLaure Couderc
- Guillaume LezmiGLGuillaume Lezmi
- Isabelle PinIPIsabelle Pin
- Isabelle PetitIPIsabelle Petit
- Philippe ReixPRPhilippe Reix
- Natacha RemusNRNatacha Remus
- Cyril SchweitzerCSCyril Schweitzer
- 16 June 2015
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (12) , 1613-1620
Abstract
The influence of the generalization of cystic fibrosis newborn screening (CFNBS) in France on sweat test (ST) prescription is unknown. In this French retrospective, descriptive, and multicenter study, we studied the indications, number, methods, and results of STs prescribed by a pediatric pulmonologist in children who had a negative CFNBS and an ST for respiratory symptoms in 2012. We included 502 children with 523 STs, performed with four different methods. The main indication was asthma (71.3 %), then chronic cough (52.4 %), atypical lower airway infections (42.2 %), and bronchiectasis (7 %). Four children had a diagnosis of CF (0.8 %), all presenting with chronic productive cough and recurrent respiratory infections. Conclusion: Asthma is the most frequent indication of ST in our cohort. Because of the systematic CFNBS in France, some prescriptions should be avoided, particularly in case of severe or moderate asthma with no other associated symptom. Moreover, methods of STs often do not follow the guidelines and need standardization. What is Known: • Newborn screening (NBS) has become the most frequent circumstance of the diagnosis of cystic fibrosis (CF) in France after its generalization. • The prescription of sweat test (ST) in children with respiratory symptoms who already had a negative NBS has not been studied. What is New: • In children with a negative CF NBS referred to a university hospital for respiratory diseases, despite important variations of ST methods, only 4 children among 502 have been diagnosed as CF. • Despite recommendations, ST prescription should be avoided in children with moderate to severe asthma and no other associated symptom. What is Known: • Newborn screening (NBS) has become the most frequent circumstance of the diagnosis of cystic fibrosis (CF) in France after its generalization. • The prescription of sweat test (ST) in children with respiratory symptoms who already had a negative NBS has not been studied. What is New: • In children with a negative CF NBS referred to a university hospital for respiratory diseases, despite important variations of ST methods, only 4 children among 502 have been diagnosed as CF. • Despite recommendations, ST prescription should be avoided in children with moderate to severe asthma and no other associated symptom.Keywords
This publication has 22 references indexed in Scilit:
- Assessment of problematic severe asthma in children: Figure 1–European Respiratory Journal, 2010
- Questions soulevées et réponses apportées depuis la généralisation du dépistage néonatal de la mucoviscidose en FranceArchives de Pédiatrie, 2009
- Le dépistage néonatal de la mucoviscidose : stratégie et résultats nationauxArchives de Pédiatrie, 2008
- [Sweat testing: review of technical requirements].Annales de biologie clinique, 2008
- Diagnostic Sweat Testing: The Cystic Fibrosis Foundation GuidelinesThe Journal of Pediatrics, 2007
- Guidelines for Evaluating Chronic Cough in PediatricsChest, 2006
- Chronic Cough Due to BronchiectasisChest, 2006
- Toux chronique de l'enfant : signes d'alarme et investigationsArchives de Pédiatrie, 2001
- Définition et aspect nosologique de la toux chronique de l'enfantArchives de Pédiatrie, 2001
- The diagnosis of cystic fibrosis: A consensus statementThe Journal of Pediatrics, 1998